Down-regulation of TSC-22 (transforming growth factor β-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo

Cancer Research

Volumn 58, Issue 3, 1998, Pages 549-555

  Nakashiro, Koh Ichi ^a   Kawamata, Hitoshi ^a   Hino, Satoshi ^a   Uchida, Daisuke ^a   Miwa, Yoshihiro ^a   Hamano, Hironori ^a   Omotehara, Fumie ^a   Yoshida, Hideo ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; MESSENGER RNA; PIPERANOMETOZINE; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CLONE; CONTROLLED STUDY; DOWN REGULATION; EXPRESSION VECTOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND CANCER; TUMOR GROWTH;

EID: 0032005230     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kawamata, H., Nakashiro, K., Uchida, D., Hino, S., Omotehara, F., Yoshida, H., and Sato, M. Induction of TSC-22 by treatment with a new anti-cancer drug, Vesnarinone, in a human salivary gland cancer cell. Br. J. Cancer, in press, 1997.
2. Sato, M., Harada, K., Bando, T., Shirakami, T., Nakashiro, K., Yoshida, H., Nakai, S., Kawai, K., and Adachi, M. Characteristics of anti-tumor activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (Vesnarinone) against a human adenoid squamous carcinoma-forming cell line grown in athymic nude mice. Cancer Lett., 91: 1-9, 1995.
3. Sato, M., Harada, K., and Yoshida, H. Induction of differentiation and apoptosis, and Ley antigen expression by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (Vesnarinone) in a human salivary cancer cell line. Acta Histochem. Cytochem., 27: 591-599, 1994.
4. Nakai, S., Kawai, K., Aihara, K., Fujita, F., Fujita, M., Sakamoto, Y., and Adachi, M. Vesnarinone 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone as an anti-tumor agent with differentiation or apoptosis inducing activity in human cancer xenografts in nude mice. Proc. Am. Assoc. Cancer Res., 35: 404, 1994.
5. Sato, M., Harada, K., Yura, Y., Bando, T., Azuma, M., Kawamata, H., Iga, H., and Yoshida, H. Induction of tumor differentiation and apoptosis and LeY antigen expression in treatment with differentiation-inducing agent Vesnarinone, of a patient with salivary adenoid cystic carcinoma. Apoptosis, 2: 106-113, 1997.
6. Sato, M., Harada, K., Yura, Y., Azuma, M., Kawamata, H., Iga, H., Tsujimoto, H., Yoshida, H., and Adachi, M. The treatment with differentiation-and apoptosis-inducing agent, Vesnarinone, of a patient with oral squamous cell carcinoma. Apoptosis, 2: 313-318, 1997.
7. Shibanuma, M., Kuroki, T., and Nose, K. Isolation of a gene encoding putative leucine zipper structure that is induced by transforming growth factor β1 and other growth factors. J. Biol. Chem., 267: 10219-10224, 1992.
8. Hamil, K. G., and Hall, S. H. Cloning of rat Sertoli cell follicle-stimulating hormone primary response complementary deoxyribonucleic acid: regulation of TSC-22 gene expression. Endocrinology, 134: 1205-1212, 1994.
9. Jay, P., Ji, J. W., Marsollier, C., Taviaux, S., Berge-Lefranc, J-L., and Berta, P. Cloning of the human homologue of the TGF-β-stimulated clone 22 gene. Biochem. Biophys. Res. Commun., 222: 821-826, 1996.
10. Yanagawa, T., Hayashi, Y., Yoshida, H., Yura, Y., Nagamine, S., Bando, T., and Sato, M. An adenoid squamous carcinoma-forming cell line established from an oral keratinizing squamous cell carcinoma expressing carcinoembryonic antigen. Am. J. Pathol., 124: 496-509, 1986.
11. Sato, M., Kawamata, H., Harada, K., Nakashiro, K., Ikeda, Y., Gohda, H., Yoshida, H., Nishida, T., Ono, K., Kinoshita, M., and Adachi, M. Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (Vesnarinone) in a human salivary cancer cell line with mutant p53 gene. Cancer Lett., 112: 181-189, 1997.
12. Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M., and Arai, N. SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol., 8: 466-472, 1988.
13. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
14. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated calorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47: 936-942, 1987.
15. Kawamata, H., Nakashiro, K., Uchida, D., Harada, K., Yoshida, H., and Sato, M. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. Int. J. Cancer, 70: 120-127, 1997.
16. Kawa-uchi, T., Nose, K., and Noda, M. Fibroblast growth factor enhances expression of TGFβ-stimulated clone-22 gene in osteoblast-like cells. Endocrine, 3: 833-837, 1995.
17. Martins, C., Fonseca, I., Roque, L., Pinto, A., E., and Soares, J. Malignant salivary gland neoplasms: a cytogenetic study of 19 cases. Eur. J. Cancer Oral Oncol., 32B: 128-132, 1996.
18. Stenman, G., Sandros, J., Mark, J., and Edstrom, S. Partial 6q deletion in a human salivary gland adenocarcinoma. Cancer Genet. Cytogenet., 39: 153-136, 1989.
19. Sandros, J., Mark, J., Happonen, R. P., and Stenman, G. Specificity of 6q-markers and other recurrent deviations in human malignant salivary gland tumors. Anticancer Res., 8: 637-643, 1988.
20. Stenman, G., Sandros, J., Dahlenfors, R., Juberg-Ode, M., and Mark, J. 6q-and loss of the Y chromosome: two common deviations in malignant human salivary gland tumors. Cancer Genet. Cytogenet., 22: 283-293, 1986.
21. Johns, M. M., III, Westra, W. H., Califona, J. A., Eisele, D., Koch, W. M., and Sidransky, D. Allelic loss of salivary gland tumors. Cancer Res., 56: 1151-1154, 1996.
22. Ah See, K. W., Cooke, T. G., Pickford, I. R., Soutar, D., and Balmain, A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res., 54: 1617-1621, 1994.
23. Jin, Y., and Mertens, F. Chromosome abnormalities in oral squamous cell carcinomas. Eur. J. Cancer Oral Oncol., 29B: 257-263, 1993.
24. Jin, Y., Mertens, F., Jin, C., Akervall, J., Wennerberg, J., Gorunova, L., Mandahl, N., Heim, S., and Mitelman, F. Nonrandom chromosome abnormalities in short-term cultured primary squamous cell carcinomas of the head and neck. Cancer Res., 55: 3204-3210, 1995.
25. Nawroz, H., van der Riet, P., Hruban, R. H., Koch, W., Ruppert, J. M., and Sidransky, D. Allelotype of head and neck squamous cells carcinoma. Cancer Res., 54: 1152-1155, 1994.
26. Yoo, G. H., Xu, H. J., Brennan, J. A., Westra, W., Hruban, R. H., Koch, W., Benedict, W. F., and Sidransky, D. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res., 54: 4603-4606, 1994.
27. Maestro, M., Piccinin, S., Doglioni, C., Gasparotto, D., Vukosavljevic, T., Sulfaro, S., Barzan, L., and Boiocchi, M. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct region of preferential loss. Cancer Res., 56: 1146-1150, 1996.
28. Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., and Dryja, T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lond.), 323: 16-22, 1986.
29. Ron, D., and Habener, J. F. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription actors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev., 6: 439-453, 1992.
30. Auwerx, J., and Sassone-Corsi, P. IP-1: a dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation. Cell, 64: 983-993, 1991.